Qualitative study of unlicensed medicines use

  • Research type

    Research Study

  • Full title

    Exploring Multidisciplinary Use of unLicenSed medicines In primary and secONdary care (EMULSION)

  • IRAS ID

    162518

  • Contact name

    Gemma Donovan

  • Contact email

    gemma.donovan@sunderland.ac.uk

  • Sponsor organisation

    University of Sunderland

  • Duration of Study in the UK

    0 years, 7 months, 1 days

  • Research summary

    Unlicensed medicines are medicines which have not undergone clinical trials, testing and evaluation associated with normal licensed medicines in the UK. They are usually used to manage specific patient needs that licensed medicines cannot meet. This project will focus on medicines which have been prescribed which do not hold a license, and therefore will not cover alternative and complementary medicines, counterfeit medicines, or use of licensed medicines for unlicensed reasons.
    Because unlicensed medicines are not manufactured by pharmaceutical companies who are ordinarily liable for any adverse reactions from the drugs they produce, the liability for the use of unlicensed medicines remains with the prescriber. However, the dispensing pharmacist will source the unlicensed medicine on the prescriber’s behalf. This means that the prescriber does not usually control where the product the patient receives is obtained from.
    We don’t have a very good understanding about what influences the decision to use unlicensed medicines and what checks and balances are in place to ensure they are used appropriately. In addition, we are not sure what information patients are given about unlicensed medicines, what their understanding is around unlicensed medicines and how they feel about the use of these medicines.
    A review of the published literature will be undertaken along with guidance and protocols which have been produced to direct professionals and provide information to patients around unlicensed medicines. This will be followed by one-to-one interviews with prescribers, pharmacists and patients from primary and secondary care. Interviews will be anonymously transcribed and analysed for themes. These themes will then be reported back to the participants from the interviews in focus groups. These focus groups will allow the results of the interviews to be tested with the participants and generate further data on their reactions to the results and potentially identify future areas for exploration.

  • REC name

    Yorkshire & The Humber - Leeds West Research Ethics Committee

  • REC reference

    15/YH/0191

  • Date of REC Opinion

    11 May 2015

  • REC opinion

    Further Information Favourable Opinion